NEJM· @NEJM · X·· 3 小时前AI 评分42
AI 导读
TRIC-I-HF试验在高危心力衰竭事件风险的重度三尖瓣反流患者中，对比了经导管三尖瓣修复联合药物治疗与单纯药物治疗。研究成果汇总于新的Quick Take视频中。https://nej.md/4xW6DWZ #ESCCongress
正文
The TRIC-I-HF trial tested transcatheter tricuspid-valve repair plus medical therapy as compared with medical therapy alone in severe tricuspid regurgitation in patients at high risk for heart-failure events. Research findings are summarized in a new Quick Take video. https://nej.md/4xW6DWZ #ESCCongress
来源：NEJM · x.com